tiprankstipranks

Lexeo Therapeutics sees cash runway into 2027

Lexeo Therapeutics sees cash runway into 2027

Cash Position: As of September 30, 2024, cash and cash equivalents were $157.0 million, which Lexeo believes will be sufficient to fund operations into 2027.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue